Literature DB >> 32162357

Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis.

Jeff Kammerman1, Andrew D Hahn1, Robert V Cadman1, Annelise Malkus1, David Mummy2,3, Sean B Fain1,4,5.   

Abstract

PURPOSE: The MR properties (chemical shifts and R 2 ∗ decay rates) of dissolved-phase hyperpolarized (HP) 129 Xe are confounded by the large magnetic field inhomogeneity present in the lung. This work improves measurements of these properties using a model-based image reconstruction to characterize the R 2 ∗ decay rates of dissolved-phase HP 129 Xe in healthy subjects and patients with idiopathic pulmonary fibrosis (IPF).
METHODS: Whole-lung MRS and 3D radial MRI with four gradient echoes were performed after inhalation of HP 129 Xe in healthy subjects and patients with IPF. A model-based image reconstruction formulated as a regularized optimization problem was solved iteratively to measure regional signal intensity in the gas, barrier, and red blood cell (RBC) compartments, while simultaneously measuring their chemical shifts and R 2 ∗ decay rates.
RESULTS: The estimation of spectral properties reduced artifacts in images of HP 129 Xe in the gas, barrier, and RBC compartments and improved image SNR by over 20%. R 2 ∗ decay rates of the RBC and barrier compartments were lower in patients with IPF compared to healthy subjects (P < 0.001 and P = 0.005, respectively) and correlated to DLCO (R = 0.71 and 0.64, respectively). Chemical shift of the RBC component measured with whole-lung spectroscopy was significantly different between IPF and normal subjects (P = 0.022).
CONCLUSION: Estimates for R 2 ∗ in both barrier and RBC dissolved-phase HP 129 Xe compartments using a regional signal model improved image quality for dissolved-phase images and provided additional biomarkers of lung injury in IPF.
© 2020 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  zzm321990 zzm321990 zzm321990 Rzzm321990 2zzm321990 zzm321990 zzm321990 zzm321990 ; MRI; hyperpolarized; idiopathic pulmonary fibrosis; lung; model-based reconstruction; xenon

Mesh:

Substances:

Year:  2020        PMID: 32162357      PMCID: PMC7329592          DOI: 10.1002/mrm.28246

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  26 in total

1.  Hyperpolarized 129Xe magnetic resonance imaging: tolerability in healthy volunteers and subjects with pulmonary disease.

Authors:  Yajur Shukla; Andrew Wheatley; Miranda Kirby; Sarah Svenningsen; Adam Farag; Giles E Santyr; Nigel A M Paterson; David G McCormack; Grace Parraga
Journal:  Acad Radiol       Date:  2012-05-15       Impact factor: 3.173

2.  In vivo MR imaging and spectroscopy using hyperpolarized 129Xe.

Authors:  M E Wagshul; T M Button; H F Li; Z Liang; C S Springer; K Zhong; A Wishnia
Journal:  Magn Reson Med       Date:  1996-08       Impact factor: 4.668

3.  Dephasing and diffusion on the alveolar surface.

Authors:  L R Buschle; F T Kurz; T Kampf; W L Wagner; J Duerr; W Stiller; P Konietzke; F Wünnemann; M A Mall; M O Wielpütz; H P Schlemmer; C H Ziener
Journal:  Phys Rev E       Date:  2017-02-24       Impact factor: 2.529

4.  Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis.

Authors:  Laura L Walkup; Robert P Thomen; Teckla G Akinyi; Erin Watters; Kai Ruppert; John P Clancy; Jason C Woods; Zackary I Cleveland
Journal:  Pediatr Radiol       Date:  2016-08-05

5.  Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients.

Authors:  Bastiaan Driehuys; Santiago Martinez-Jimenez; Zackary I Cleveland; Gregory M Metz; Denise M Beaver; John C Nouls; S Sivaram Kaushik; Rafael Firszt; Christine Willis; Kevin T Kelly; Jan Wolber; Monica Kraft; H Page McAdams
Journal:  Radiology       Date:  2011-11-04       Impact factor: 11.105

Review 6.  The role of hyperpolarized 129xenon in MR imaging of pulmonary function.

Authors:  Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain
Journal:  Eur J Radiol       Date:  2016-09-16       Impact factor: 3.528

7.  A protocol for quantifying cardiogenic oscillations in dynamic 129 Xe gas exchange spectroscopy: The effects of idiopathic pulmonary fibrosis.

Authors:  Elianna A Bier; Scott H Robertson; Geoffry M Schrank; Craig Rackley; Joseph G Mammarappallil; Sudarshan Rajagopal; H Page McAdams; Bastiaan Driehuys
Journal:  NMR Biomed       Date:  2018-11-20       Impact factor: 4.044

8.  Abnormalities in hyperpolarized (129)Xe magnetic resonance imaging and spectroscopy in two patients with pulmonary vascular disease.

Authors:  Talal Dahhan; Shiv S Kaushik; Mu He; Joseph G Mammarappallil; Victor F Tapson; Holman P McAdams; Thomas A Sporn; Bastiaan Driehuys; Sudarshan Rajagopal
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

9.  Hyperpolarized Xe MR imaging of alveolar gas uptake in humans.

Authors:  Zackary I Cleveland; Gary P Cofer; Gregory Metz; Denise Beaver; John Nouls; S Sivaram Kaushik; Monica Kraft; Jan Wolber; Kevin T Kelly; H Page McAdams; Bastiaan Driehuys
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

10.  129 Xe chemical shift in human blood and pulmonary blood oxygenation measurement in humans using hyperpolarized 129 Xe NMR.

Authors:  Graham Norquay; General Leung; Neil J Stewart; Jan Wolber; Jim M Wild
Journal:  Magn Reson Med       Date:  2016-04-08       Impact factor: 4.668

View more
  1 in total

1.  Utilizing flip angle/TR equivalence to reduce breath hold duration in hyperpolarized 129 Xe 1-point Dixon gas exchange imaging.

Authors:  Peter J Niedbalski; Junlan Lu; Chase S Hall; Mario Castro; John P Mugler; Yun M Shim; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2021-10-13       Impact factor: 4.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.